Reverse Translation: The Art of Cyclical Learning

We live in an era of precision therapeutics, value‐based healthcare, patient‐participatory research, and enhanced clinical trial transparency, with explosive increases in our ability to access and analyze multiscale biological and clinical data from diverse ecosystems. To discover and develop truly transformative medicines with a patient‐centric sense of urgency, we will need to exploit data that lie far beyond the confines of laboratory‐based experimental models and controlled clinical trials, dynamically maximizing the value of information in real‐world data from clinical practice settings and even social media. This demands commitment to a culture that embraces Reverse Translation as a critical component of the practice of Translational Medicine in the discovery, development, regulation, and utilization of therapeutics.

[1]  R. Altman,et al.  Challenges for Training Translational Researchers in the Era of Ubiquitous Data , 2018, Clinical pharmacology and therapeutics.

[2]  Nicholas P Tatonetti,et al.  The Next Generation of Drug Safety Science: Coupling Detection, Corroboration, and Validation to Discover Novel Drug Effects and Drug–Drug Interactions , 2018, Clinical pharmacology and therapeutics.

[3]  Amin Rostami‐Hodjegan,et al.  Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence , 2017, Clinical pharmacology and therapeutics.

[4]  R. Kurzrock,et al.  Molecular Tumor Boards: Realizing Precision Oncology Therapy , 2018, Clinical pharmacology and therapeutics.

[5]  A. Kerlavage,et al.  Cancer Moonshot Data and Technology Team: Enabling a National Learning Healthcare System for Cancer to Unleash the Power of Data , 2017, Clinical pharmacology and therapeutics.

[6]  L. Johannesen,et al.  Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes , 2018, Clinical pharmacology and therapeutics.

[7]  J. Tait,et al.  Challenges and opportunities. , 1996, Journal of psychiatric and mental health nursing.

[8]  S‐M Huang,et al.  Cancer Therapy: Shooting for the Moon , 2017, Clinical pharmacology and therapeutics.

[9]  H. Tomkinson,et al.  Harnessing Meta‐analysis to Refine an Oncology Patient Population for Physiology‐Based Pharmacokinetic Modeling of Drugs , 2018, Clinical pharmacology and therapeutics.

[10]  J. Gibbs,et al.  Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development , 2017, Clinical pharmacology and therapeutics.

[11]  Amy P. Abernethy,et al.  Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality , 2017, Clinical pharmacology and therapeutics.

[12]  Model‐Informed Reverse and Forward Translation of Safety Risks in Drug Development , 2018, Clinical pharmacology and therapeutics.

[13]  Lei Wang,et al.  Translational High‐Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models , 2018, Clinical pharmacology and therapeutics.

[14]  B. '. ’t Hart,et al.  Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery , 2018, Clinical pharmacology and therapeutics.

[15]  Girish Dwivedi,et al.  Sushruta -the clinician : Teacher par excellence , 2007 .

[16]  Heidi L. Burdett,et al.  Shooting for the Moon , 2016, Nature Microbiology.

[17]  K. Giacomini,et al.  Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response , 2018, Clinical pharmacology and therapeutics.

[18]  R. Weinshilboum,et al.  Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study , 2017, Clinical pharmacology and therapeutics.

[19]  J. Beckmann,et al.  Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities , 2016, Genome Medicine.

[20]  A. Doney,et al.  Investigating Real‐World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records , 2017, Clinical pharmacology and therapeutics.

[21]  S. Dorajoo,et al.  Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy , 2018, Clinical pharmacology and therapeutics.

[22]  L. Lesko.  Efficacy From Strange Sources , 2018, Clinical pharmacology and therapeutics.

[23]  C. L. Shaffer.  Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery , 2018, Clinical pharmacology and therapeutics.

[24]  Sreeneeranj Kasichayanula,et al.  How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development? , 2018, Clinical pharmacology and therapeutics.

[25]  E. Puijenbroek,et al.  When More Is Less: An Exploratory Study of the Precautionary Reporting Bias and Its Impact on Safety Signal Detection , 2018, Clinical pharmacology and therapeutics.